<i>PIK3CA</i>-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution.

Mosaicism is increasingly recognized as a cause of developmental disorders with the advent of next-generation sequencing (NGS). Mosaic mutations of &lt;i&gt;PIK3CA&lt;/i&gt; have been associated with the widest spectrum of phenotypes associated with overgrowth and vascular malformations. We performed targeted NGS using 2 independent deep-coverage methods that utilize molecular inversion probes and amplicon sequencing in a cohort of 241 samples from 181 individuals with brain and/or body overgrowth. We identified &lt;i&gt;PIK3CA&lt;/i&gt; mutations in 60 individuals. Several other individuals ( &lt;i&gt;n&lt;/i&gt; = 12) were identified separately to have mutations in &lt;i&gt;PIK3CA&lt;/i&gt; by clinical targeted-panel testing ( &lt;i&gt;n&lt;/i&gt; = 6), whole-exome sequencing ( &lt;i&gt;n&lt;/i&gt; = 5), or Sanger sequencing ( &lt;i&gt;n&lt;/i&gt; = 1). Based on the clinical and molecular features, this cohort segregated into three distinct groups: (a) severe focal overgrowth due to low-level but highly activating (hotspot) mutations, (b) predominantly brain overgrowth and less severe somatic overgrowth due to less-activating mutations, and (c) intermediate phenotypes (capillary malformations with overgrowth) with intermediately activating mutations. Sixteen of 29 &lt;i&gt;PIK3CA&lt;/i&gt; mutations were novel. We also identified constitutional &lt;i&gt;PIK3CA&lt;/i&gt; mutations in 10 patients. Our molecular data, combined with review of the literature, show that &lt;i&gt;PIK3CA&lt;/i&gt; -related overgrowth disorders comprise a discontinuous spectrum of disorders that correlate with the severity and distribution of mutations